Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1β

Journal of Endocrinology

Volumn 192, Issue 2, 2007, Pages 381-387

  Börjesson, Andreas ^a   Carlsson, Carina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; PROINSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOPRECIPITATION; INSULIN METABOLISM; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; HYDROXYMETHYLBILANE SYNTHASE; IMMUNOPRECIPITATION; INSULIN; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; PROINSULIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 33947368311     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06676     Document Type: Article

References (35)

1. Alarcon C, Lincoln B & Rhodes CJ 1993 The biosynthesis of the subtilisin-related proprotein converrase PC3, but not that of the PC2 convertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets. Journal of Biological Chemistry 268 4276-4280.
2. Alarcon C, Leahy JL, Schuppin GT & Rhodes CJ 1995 Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 95 1032-1039.
3. Bailyes EM, Shennan KI, Seal AJ, Smeekens SP, Steiner DF, Hutton JC & Docherty K 1992 A member of the eukaryotic subtilism family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase. Biochemical Journal 285 391-394.
4. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA & Svenson M 1986 Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232 1545-1547.
5. Bennett DL, Bailyes EM, Nielsen E, Guest PC, Rutherford NG, Arden SD & Hutton JC 1992 Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. Journal of Biological Chemistry 267 15229-15236.
6. Duckworth WC & Kitabchi AE 1972 Direct measurement of plasma proinsulin in normal and diabetic subjects. American Journal of Medicine 53 418-427.
7. Gadot M, Ariav Y, Cerasi E, Kaiser N & Gross DJ 1995 Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell. Endocrinology 136 4218-4223.
8. Gordon P, Hendricks CM & Roth J 1974 Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states. Diabetologia 10 469-474.
9. Haffner SM, Bowsher RR, Mykkanen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A & Stern MP 1994 Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes 43 1490-1493.
10. Hansen BS, Nielsen JH, Linde S, Spinas GA, Welinder BS, Mandrup-Poulsen T & Nerup J 1988 Effect of interleukin-1 on the biosynthesis of proinsulin and insulin in isolated rat pancreatic islets. Biomedica Biochimica Acta 47 305-309.
11. Hartling SG, Lindgren F, Dahlqvist G, Persson B & Binder C 1989 Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 38 1271-1274.
12. Heding LG, Ludvigsson J & Kasperska-Czyzykowa T 1981 B-cell secretion in non-diabetics and insulin-dependent diabetics. Acta Medica Scandinavica. Supplementum 659 5-9.
13. Hostens K, Pavlovic D, Zambre Y, Ling Z, Van Schravendijk C, Eizirik DL & Pipeleers DG 1999 Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. Journal of Clinical Investigation 104 67-72.
14. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW & Fujimoto WY 1995 Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44 173-179.
15. Leahy JL 1993 Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats. Diabetes 42 22-27.
16. Leahy JL, Halban PA & Weir GC 1991 Relative hypersecretion of proinsulin in rat model of NIDDM. Diabetes 40 985-989.
17. Ludvigsson J & Heding LG 1982 Abnormal proinsulin/C peptide ratio in juvenile diabetes. Acta Diabetologica Latina 19 351-358.
18. Mako ME, Starr JI & Rubenstein AH 1977 Circulating proinsulin in patients with maturity onset diabetes. American Journal of Medicine 63 865-869.
19. Martin SK, Carroll R, Benig M & Steiner DF 1994 Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Letters 356 279-282.
20. Mykkannen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN & Laakso M 1995 Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38 1176-1182.
21. Nagamatsu S, Bolaffi JL & Grodsky GM 1987 Direct effects of glucose on proinsulin synthesis and processing during desensitization. Endocrinology 120 1225-1231.
22. Rhodes CJ & Halban PA 1987 Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. Journal of Cell Biology 105 145-153.
23. Roder ME, Vaag A, Hartling SG, Dinesen B, Lanng S, Beck-Nielsen H & Binder C 1995 Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellicus. Journal of Clinical Endocrinology and Metabolism 80 2359-2363.
24. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH & Porte D Jr 1990 Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 70 1247-1253.
25. Sandler S, Andersson A & Hellerstrom C 1987 Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121 1424-1431.
26. Sandler S, Bendtzen K, Eizirik DL, Strandell E, Welsh M & Welsh N 1991 Prolonged exposure of pancreatic islets isolated from 'pre-diabetic' non-obese diabetic mice to a high glucose concentration does not impair beta-cell function. Diabetologia 34 6-11.
27. Schuppin GT & Rhodes CJ 1996 Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing beta TC3 cells. Biochemical Journal 313 259-268.
28. Snorgaard O, Harding SG & Binder C 1990 Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33 36-42.
29. Spinas GA, Snorgaard O, Hartling SG, Oberholzer M & Berger W 1992 Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients. Diabetes Care 15 632-637.
30. Steiner DF, Kemmler W, Clark JL, Oyer PE & Rubenstein AH 1972 The biosynthesis of insulin. In Handbook of Physiology, vol 1, pp 175-198. Eds N Freinkel & DF Steiner (The endocrine pancreas).
31. Steiner DF, Rouille Y, Gong Q, Martin S, Carroll R & Chan SJ 1996 The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals. Diabetes and Metabolism 22 94-104 (Review).
32. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey VJ & Hales CN 1989 Insulin deficiency in non-insuhn-dependent diabetes. Lancet 1293-295.
33. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ & Porte D Jr 1987 Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30 698-702.
34. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M & Iwamoto Y 1988 Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31 355-360.
35. Zambre Y, Van Schravendijk C & Ling Z 2001 Interleukin-1 beta inhibits proinsulin conversion in rat beta-cells via a nitric oxide-dependent pathway. Hormone and Metabolic Research 33 639-644.